Cargando…

Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis

Detalles Bibliográficos
Autores principales: Megremis, Spyridon, Walker, Thomas D J, He, Xiaotong, Ollier, William E R, Chinoy, Hector, Hampson, Lynne, Hampson, Ian, Lamb, Janine A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509518/
https://www.ncbi.nlm.nih.gov/pubmed/32444414
http://dx.doi.org/10.1136/annrheumdis-2020-217522
_version_ 1783585613457391616
author Megremis, Spyridon
Walker, Thomas D J
He, Xiaotong
Ollier, William E R
Chinoy, Hector
Hampson, Lynne
Hampson, Ian
Lamb, Janine A
author_facet Megremis, Spyridon
Walker, Thomas D J
He, Xiaotong
Ollier, William E R
Chinoy, Hector
Hampson, Lynne
Hampson, Ian
Lamb, Janine A
author_sort Megremis, Spyridon
collection PubMed
description
format Online
Article
Text
id pubmed-7509518
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-75095182020-10-05 Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis Megremis, Spyridon Walker, Thomas D J He, Xiaotong Ollier, William E R Chinoy, Hector Hampson, Lynne Hampson, Ian Lamb, Janine A Ann Rheum Dis Letter BMJ Publishing Group 2020-10 2020-05-22 /pmc/articles/PMC7509518/ /pubmed/32444414 http://dx.doi.org/10.1136/annrheumdis-2020-217522 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter
Megremis, Spyridon
Walker, Thomas D J
He, Xiaotong
Ollier, William E R
Chinoy, Hector
Hampson, Lynne
Hampson, Ian
Lamb, Janine A
Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis
title Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis
title_full Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis
title_fullStr Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis
title_full_unstemmed Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis
title_short Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis
title_sort antibodies against immunogenic epitopes with high sequence identity to sars-cov-2 in patients with autoimmune dermatomyositis
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509518/
https://www.ncbi.nlm.nih.gov/pubmed/32444414
http://dx.doi.org/10.1136/annrheumdis-2020-217522
work_keys_str_mv AT megremisspyridon antibodiesagainstimmunogenicepitopeswithhighsequenceidentitytosarscov2inpatientswithautoimmunedermatomyositis
AT walkerthomasdj antibodiesagainstimmunogenicepitopeswithhighsequenceidentitytosarscov2inpatientswithautoimmunedermatomyositis
AT hexiaotong antibodiesagainstimmunogenicepitopeswithhighsequenceidentitytosarscov2inpatientswithautoimmunedermatomyositis
AT ollierwilliamer antibodiesagainstimmunogenicepitopeswithhighsequenceidentitytosarscov2inpatientswithautoimmunedermatomyositis
AT chinoyhector antibodiesagainstimmunogenicepitopeswithhighsequenceidentitytosarscov2inpatientswithautoimmunedermatomyositis
AT hampsonlynne antibodiesagainstimmunogenicepitopeswithhighsequenceidentitytosarscov2inpatientswithautoimmunedermatomyositis
AT hampsonian antibodiesagainstimmunogenicepitopeswithhighsequenceidentitytosarscov2inpatientswithautoimmunedermatomyositis
AT lambjaninea antibodiesagainstimmunogenicepitopeswithhighsequenceidentitytosarscov2inpatientswithautoimmunedermatomyositis